Theravance Biopharma Inc
Ownership
Ownership Structure
Who owns Theravance Biopharma Inc (TBPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 49.8% of the shares are freely tradable; institutional investors hold 99.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Madison Avenue Partners, LP | 17.74 | 9,212,252 | -3.1 | 06/30/2026 |
| Weiss Asset Management LP | 14.36 | 7,457,060 | +0.0 | 06/30/2026 |
| BlackRock Inc | 8.79 | 4,562,487 | +6.2 | 06/30/2026 |
| Newtyn Management LLC | 6.61 | 3,434,191 | -29.1 | 06/30/2026 |
| Irenic Capital Management LP | 5.32 | 2,760,948 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.41 | 1,771,493 | -0.7 | 06/30/2026 |
| State Street Corp | 2.56 | 1,328,584 | +2.4 | 06/30/2026 |
| Two Sigma Investments LLC | 2.36 | 1,225,587 | -2.6 | 06/30/2026 |
| D. E. Shaw & Co LP | 2.28 | 1,185,390 | +24.2 | 06/30/2026 |
| Acadian Asset Management LLC | 2.26 | 1,174,910 | -8.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Samaha Eli | 10% Owner | 9,167,489 | 155,847,313 $ | Jul 7, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Weiss Asset Management LP | Former 10% Owner | Other | 7,457,060 | 17.00 | 126,770,020 |
| Sep 23, 2026 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Other | 96,718 | – | – |
| Sep 23, 2026 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Other | 93,108 | – | – |
| Sep 23, 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Other | 23,439 | – | – |
| Sep 23, 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Other | 107,812 | – | – |
| Sep 23, 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Other | 223,917 | – | – |
| Sep 23, 2026 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Other | 23,439 | – | – |
| Sep 23, 2026 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Other | 108,436 | – | – |
| Sep 23, 2026 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Other | 204,966 | – | – |
| Sep 23, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Other | 89,062 | – | – |
| Sep 23, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Other | 124,414 | – | – |
| Sep 23, 2026 | Gray Susannah | Director | Other | 6,009 | – | – |
| Sep 23, 2026 | Gray Susannah | Director | Other | 42,137 | – | – |
| Sep 23, 2026 | O'Connor Donal | Director | Other | 6,009 | – | – |
| Sep 23, 2026 | O'Connor Donal | Director | Other | 74,204 | – | – |
| Sep 23, 2026 | Smaldone Alsup Laurie | Director | Other | 6,009 | – | – |
| Sep 23, 2026 | Smaldone Alsup Laurie | Director | Other | 74,980 | – | – |
| Sep 23, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 92,567 | – | – |
| Sep 23, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 23,400 | – | – |
| Sep 23, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 76,875 | – | – |
| Sep 23, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 151,875 | – | – |
| Sep 23, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 1,382,272 | – | – |
| Sep 23, 2026 | Pakianathan Deepika | Director | Other | 6,009 | – | – |
| Sep 23, 2026 | Pakianathan Deepika | Director | Other | 58,065 | – | – |
| Sep 23, 2026 | Mitchell Dean J | Director | Other | 6,009 | – | – |
| Sep 23, 2026 | Mitchell Dean J | Director | Other | 91,204 | – | – |
| Sep 15, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 6,657 | 17.03 | 113,397 |
| Sep 15, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,328 | 17.03 | 56,690 |
| Sep 15, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,329 | 17.03 | 56,707 |
| Aug 20, 2026 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Other | 6,258 | 16.95 | 106,073 |
| Aug 20, 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Other | 7,952 | 16.95 | 134,786 |
| Aug 20, 2026 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Other | 8,112 | 16.95 | 137,498 |
| Aug 20, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Other | 5,667 | 16.95 | 96,056 |
| Aug 20, 2026 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Other | 20,034 | 16.95 | 339,576 |
| Jul 7, 2026 | Samaha Eli | 10% Owner | Sell | 5,564 | 17.17 | 95,541 |
| Jul 6, 2026 | Samaha Eli | 10% Owner | Sell | 1,400 | 17.04 | 23,856 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.